1. Home
  2. Analysis
  3. Aimovig
  4. Naloxone

Aimovig and Naloxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Aimovig and Naloxone. Common interactions include cerebrovascular accident among females, and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people who take Aimovig and Naloxone have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2023

6 people who take Aimovig and Naloxone together, and have interactions are studied.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. Currently, eHealthMe is studying from 44,967 Aimovig users.

What is Naloxone?

Naloxone has active ingredients of naloxone hydrochloride. Currently, eHealthMe is studying from 5,693 Naloxone users.

Number of Aimovig and Naloxone reports submitted per year:

Aimovig and Naloxone drug interactions.

Common Aimovig and Naloxone drug interactions by gender *:

female:

  1. Cerebrovascular accident
  2. Renal impairment
  3. Seizure
  4. Ankylosing spondylitis
  5. Blood pressure increased

male:

  1. Cerebrovascular accident
  2. Asthenia
  3. Blood bilirubin increased
  4. Headache
  5. Leukocytosis
  6. Nausea
  7. Reticulocyte count increased
  8. Transaminases increased

Common Aimovig and Naloxone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthenia
  2. Blood bilirubin increased
  3. Headache
  4. Leukocytosis
  5. Nausea
  6. Reticulocyte count increased
  7. Transaminases increased

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cerebrovascular accident
  2. Ankylosing spondylitis

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Naloxone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Aimovig drug interactions:

Browse interactions between Aimovig and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Naloxone drug interactions:

Browse interactions between Naloxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on erenumab-aooe and naloxone hydrochloride (the active ingredients of Aimovig and Naloxone, respectively), and Aimovig and Naloxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Aimovig and Naloxone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.